MOTE Therapeutics
PrivateLast Round
Series A
Jul 3, 2025
Company Overview
MOTE Therapeutics is a biotechnology company developing a next-generation RNA delivery platform to transport RNA payloads to cells and tissues outside the liver.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOTE Therapeutics Comparables
Compare MOTE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Starna Therapeutics | 86% | |
| NanoVation Therapeutics | 85% | |
| Liberate Bio | 83% |
MOTE Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 3, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
$40M round completed.
MOTE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MOTE Therapeutics's valuation, stock price, and market status.
Is MOTE Therapeutics a public or private company?
MOTE Therapeutics is a private company.
What is the current stock price of MOTE Therapeutics?
MOTE Therapeutics is a private company, so its shares have no public market price. Caplight tracks MOTE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MOTE Therapeutics worth (valuation)?
Valuation information for MOTE Therapeutics is not publicly available.
Can I buy MOTE Therapeutics stock?
MOTE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MOTE Therapeutics's last funding round?
MOTE Therapeutics's most recent funding round was Series A on July 3, 2025.
Who are the main investors in MOTE Therapeutics?
Investor information for MOTE Therapeutics is not publicly disclosed.
Will MOTE Therapeutics IPO soon?
No public IPO plans have been announced for MOTE Therapeutics.
How can I track MOTE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in MOTE Therapeutics's shares on secondary markets.